Celluvisc
Celluvisc is a medicine authorised by Swissmedic under authorisation number 52073. The authorisation holder is AbbVie AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 19 April 1993 and the authorisation is valid without a time limit. ATC code S01XA20 places the medicine in the group Ophthalmologicals.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Celluvisc, Augentropfen | D | 19 April 1993 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 22 | 30 x 0,4 | ml | S01XA20 | 11.08.2. | D |
| 49 | 90 x 0,4 | ml | S01XA20 | 11.08.2. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Celluvisc authorised in Switzerland?
Yes. Celluvisc is authorised by Swissmedic under authorisation number 52073, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Celluvisc have?
Celluvisc is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Celluvisc?
The authorisation holder is AbbVie AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.